Search
Descriptor English: AC133 Antigen
Descriptor Spanish: Antígeno AC133
Descriptor antígeno AC133
Entry term(s) PROML1
PROML1 tipo prominina
antígeno AC133-1
antígeno AC133-2
antígeno AC141
antígeno CD133
fudenina
prominina
prominina-1
Scope note: El antígeno AC133 es un antígeno 5-transmembranario, miembro de la familia de la prominina que existe en distintas isoformas producidas por corte y empalme alternativo y que son procesadas para dar las formas maduras. En los seres humanos se expresa en un subconjunto de células madre hematopoyéticas humanas CD34 (brillantes) y leucemias CD34 positivas. Se asocia con funciones en la diferenciación, proliferación y apoptosis celular. Regula, de forma específica, la organización de la membrana apical en las células epiteliales, la morfogénesis del disco en el desarrollo inicial de la retina, las vías de señalización MAPK y Akt y en el metabolismo del colesterol.
Descriptor Portuguese: Antígeno AC133
Descriptor French: Antigène AC133
Entry term(s): AC133 1 Antigen
AC133 2 Antigen
AC133-1 Antigen
AC133-2 Antigen
AC141 Antigen
Antigen, AC133
Antigen, AC133-1
Antigen, AC133-2
Antigen, AC141
Antigen, CD133
CD133 Antigen
Fudenine
PROML1
Prominin
Prominin 1
Prominin Like PROML1
Prominin-1
Prominin-Like PROML1
Tree number(s): D09.400.430.890.007
D12.776.395.550.007
D12.776.543.550.023
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D000071916
Scope note: A member of the prominin family, AC133 Antigen is a 5-transmembrane antigen occurring as several isoforms produced by alternative splicing which are processed into mature forms. In humans, it is expressed as a subset of CD34 (bright) human hematopoietic stem cells and CD34 positive leukemias. Functionally, it is associated with roles in cell differentiation, proliferation, and apoptosis. Specifically, it regulates the organization of apical plasma membrane in epithelial cells, disk morphogenesis during early retinal development, MAPK and Akt signaling pathways, and in cholesterol metabolism.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AG agonists
AI antagonists & inhibitors
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
DE drug effects
DF deficiency
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UL ultrastructure
UR urine
Public MeSH Note: 2017; AC133 ANTIGEN was indexed under GLYCOPROTEINS, PEPTIDES and ANTIGENS, CD 1998-2016
History Note: 2017(1998)
Related: Antigen-Antibody Reactions MeSH
DeCS ID: 56518
Unique ID: D000071916
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2017/01/01
Date of Entry: 2016/07/08
Revision Date: 2017/05/24
AC133 Antigen - Preferred
Concept UI M0288458
Scope note A member of the prominin family, AC133 Antigen is a 5-transmembrane antigen occurring as several isoforms produced by alternative splicing which are processed into mature forms. In humans, it is expressed as a subset of CD34 (bright) human hematopoietic stem cells and CD34 positive leukemias. Functionally, it is associated with roles in cell differentiation, proliferation, and apoptosis. Specifically, it regulates the organization of apical plasma membrane in epithelial cells, disk morphogenesis during early retinal development, MAPK and Akt signaling pathways, and in cholesterol metabolism.
Preferred term AC133 Antigen
Entry term(s) AC133 1 Antigen
AC133-1 Antigen
Antigen, AC133
Antigen, AC133-1
Antigen, CD133
CD133 Antigen
Fudenine
PROML1
Prominin
Prominin 1
Prominin Like PROML1
Prominin-1
Prominin-Like PROML1
AC141 Antigen - Narrower
Concept UI M000617722
Preferred term AC141 Antigen
Entry term(s) Antigen, AC141
AC133-2 Antigen - Narrower
Concept UI M000617723
Preferred term AC133-2 Antigen
Entry term(s) AC133 2 Antigen
Antigen, AC133-2



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.


Go to survey